Tessera
Folgen

Behnood Bikdeli, MD, MS

@bbikdeli.bsky.social

Father, husband, cardiologist 🫀, investigator, #thrombosis, #antithrombotic therapy

10 Posts81 Follower45 Folgt
Nature Reviews Cardiology@natrevcardiol.nature.com · last mo.

New online! Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism #CardioSky

Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism

Nature Reviews Cardiology, Published online: 27 September 2026; doi:10.1038/s41569-026-01334-3Venous thromboembolism (VTE) is a major cause of morbidity and death. In this Review, Bikdeli and colleagues summarize the available evidence on the worldwide incidence and outcomes of VTE, specifically deep-vein thrombosis and pulmonary embolism. Their findings reveal a substantial and, in some regions, increasing burden of disease, sources of heterogeneity and striking regional gaps in the data.

dlvr.it

Nature Reviews Cardiology@natrevcardiol.nature.com · 8mo ago

New online! Antiphospholipid antibodies and cardiovascular thrombosis #CardioSky

Antiphospholipid antibodies and cardiovascular thrombosis

Nature Reviews Cardiology, Published online: 10 March 2026; doi:10.1038/s41569-026-01269-9Antiphospholipid antibodies (aPL) are associated with an elevated risk of thromboembolic events in patients with antiphospholipid syndrome and, increasingly, in those without previous thrombosis. In this Review, Bikdeli and colleagues discuss the clinical relevance of aPL seropositivity in predicting the risk of thrombotic cardiovascular events, summarize potential management strategies and identify key knowledge gaps that warrant further research.

dlvr.it

Geoffrey Barnes, MD, MSc@gbarnesmd.bsky.social · 11mo ago

There was so much to cover in 2025... we only were able to discuss the "tip of the iceberg." Still - so much great science that we explored togehter. Thanks @bbikdeli.bsky.social for joining me on the podcast!

Medthority@medthority.bsky.social · 11mo ago

Tune in to hear @gbarnesmd.bsky.social and @bbikdeli.bsky.social present their round-up of this year's major advances in VTE and AF management. Stay ahead in thrombosis care with insights on recent trial data and the shift towards treatment personalization #MedSky #CardioSky ow.ly/Lnm450XBnMr

JAMA@jama.com · last yr.

Superficial vein thrombosis (SuVT) is characterized by thrombus in the superficial veins, typically in the lower or upper extremities. This Review summarizes the diagnosis and treatment of SuVT. ja.ma/4mlIxPL

Diagram from JAMA, Sept 15, 2025, titled "Superficial Vein Thrombosis: A Review." It shows common sites and pathophysiology of SuVT in upper and lower extremities, detailing vein names, thrombus formation, inflammation, and impeded blood flow.
Ken Covinsky@kencovinsky.bsky.social · 2y ago

Distressing account of how The FDA regulatory process failed patients The Cook Celect IVC Filters: Failure to disclose serious harms including IVC rupture and death. We must learn the lessons from this scandal www.acpjournals.org/doi/10.7326/...

Information Disclosure, Medical Device Regulation, and Device Safety: The Case of Cook Celect IVC Filters | Annals of Internal Medicine

Although medical devices are widely used in clinical practice, clinicians and the public have limited access to information on how devices are tested, regulated, and used, posing challenges to patient...

acpjournals.org

Behnood Bikdeli, MD, MS@bbikdeli.bsky.social · 2y ago

😂😂Thank you so much @gbarnesmd.bsky.social for ur extremely kind words and for covering our study! Lots of credit to Sina for leading the effort, to the trial PIs who kindly helped w study-level unpublished data for certain outcomes/subgroups, and to team! 👏

Geoffrey Barnes, MD, MSc@gbarnesmd.bsky.social · 2y ago

When does @bbikdeli.bsky.social sleep? I'm not sure - he's constantly publishing highly impactful work!! This week is no different. Check out this important meta-analysis on #cvCoag and #antiplatleet use in #AFib and stable #CAD! Less is more!!! @jaccjournals.bsky.social www.jacc.org/doi/10.1016/...

Saskia Middeldorp@middeldorps.bsky.social · 2y ago

Publication alert 📣! How to prevent #postpartum #VTE in women at moderate risk? Outcomes of the PILOTPARTUM pilot have been published in Lancet Hematology. Kudos to Dr Leslie Skeith and all passionate colleagues, and to all women who participated! www.sciencedirect.com/science/arti...

Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial

Despite the morbidity and mortality of venous thromboembolism, there is little evidence to guide postpartum thromboprophylaxis in patients at moderate…

sciencedirect.com